High Cost Drugs
- Collect the NICE/SMC/HSE criteria led evidence directly from the Provider Clinicians themselves
- Using Auto-Approval, ensure that Clinicians receive the approval to treat immediately
- Keep a complete audit trail of the process
- Validate/Challenge provider invoices with ease
NICE raises cost-effectiveness threshold for the first time in 26 years
Introduction
Paperless Solution
Getting rid of paper forms to collect evidence of NICE criteria being followed not only streamlines the process for the commissioner, it also gives the clinician a transparent view of the process on their screens. With the multitude of different commissioners, the system effortlessly guides the user to the correct form to complete.
Request History & Document Storage
The Blueteq High Cost/PBRE Drugs system provides a complete patient history storing and displaying all information and documentation in one place in a paperless environment. No filing is required and all vital data is immediately to hand. E-mails can be sent directly from the system, including attachments, to further facilitate processing. The system means that you have complete visibility of all requests, their current status and value. All the communication and documents held on the system are available for subsequent review and the system provides a full patient history on a single screen with all associated documentation and notes immediately to hand.
Customised Reporting
A full range of reports are available on demand to help prioritise work-loads, ensure that all requests are processed in a timely manner and within the target timescales and all follow up actions are captured.
Seamless Integration
The Blueteq High Cost Drugs system is designed to integrate seamlessly with the healthcare IT infrastructure used across each of the jurisdictions in which it operates or is being considered. Whether working alongside Epic (Encompass) in Northern Ireland's HSC Trusts, the AWTTC and WHSSC governance framework in Wales, NHS England's Integrated Care Board commissioning systems, the Scottish Medicines Consortium's approval processes, Jersey's Health and Community Services, or the HSE and NCPE reimbursement pathway in the Republic of Ireland — Blueteq adapts to the systems already in place rather than requiring wholesale change.
WHY CHOOSE US
Unique Benefits Summary: High Cost Drugs
- Highlight discrepancies, saving 15–20% on invoice values — a direct, measurable financial return
- Reduce unnecessary spending by 2% through rigorous eligibility gate-keeping at the point of prescribing
- Maximise the budget's impact on patient care by eliminating waste and directing savings to the front line
- Match invoices to requests in minutes — saving up to a day in staff time per invoice cycle
- Streamline workflows for faster, more reliable approvals — average form completion just 5–10 minutes
- Enhance transparency: combined clinical and financial data in one secure, auditable system
- Drive quality improvements through advanced reporting capabilities — on-demand reports in minutes, not hours
- Guarantee treatments align with commissioning criteria — clinicians receive precise, patient-specific eligibility forms
- Ensure prompt payment for authorised requests — automatic invoice matching removes dispute delays
- Simplify request submissions through a unified platform: no paper, no lost forms, no chasing approvals
- Gain complete visibility into request statuses and review historical patient data on a single screen
- No software to install and maintain locally — web-based, no local installation required
- No expensive initial licence fees — simple, predictable subscription basis
